Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...
SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
FREMONT, Calif. & LAS VEGAS--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced positive clinical results from the pooled DISRUPT PAD ...
FREMONT, Calif. & WASHINGTON--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today reported positive safety, performance and intravascular imaging ...
Shockwave Medical, Inc. SWAV, along with Genesis MedTech Group, received approval from China’s National Medical Products Administration for Intravascular Lithotripsy (“IVL”). The clearance paves the ...
FREMONT, Calif., Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty ® ...
MARIETTA, GA - May 20, 2026 - - Shockwave Centers of America has outlined the science behind shockwave therapy as a ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — In patients with calcified peripheral artery disease undergoing drug-coated balloon treatment, ...
We have moved interventional procedures guidance 742 to become HealthTech guidance 645. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results